SILK vs. KIDS, FNA, ATRI, TMCI, SIBN, AORT, EMBC, ATRC, IRMD, and MDXG
Should you be buying Silk Road Medical stock or one of its competitors? The main competitors of Silk Road Medical include OrthoPediatrics (KIDS), Paragon 28 (FNA), Atrion (ATRI), Treace Medical Concepts (TMCI), SI-BONE (SIBN), Artivion (AORT), Embecta (EMBC), AtriCure (ATRC), Iradimed (IRMD), and MiMedx Group (MDXG). These companies are all part of the "surgical & medical instruments" industry.
Silk Road Medical (NASDAQ:SILK) and OrthoPediatrics (NASDAQ:KIDS) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, valuation, dividends, profitability, risk, earnings, analyst recommendations, institutional ownership and community ranking.
Silk Road Medical currently has a consensus target price of $22.55, indicating a potential upside of 7.21%. OrthoPediatrics has a consensus target price of $45.50, indicating a potential upside of 46.35%. Given OrthoPediatrics' stronger consensus rating and higher probable upside, analysts plainly believe OrthoPediatrics is more favorable than Silk Road Medical.
Silk Road Medical has a beta of 1.43, indicating that its share price is 43% more volatile than the S&P 500. Comparatively, OrthoPediatrics has a beta of 1.16, indicating that its share price is 16% more volatile than the S&P 500.
In the previous week, OrthoPediatrics had 22 more articles in the media than Silk Road Medical. MarketBeat recorded 24 mentions for OrthoPediatrics and 2 mentions for Silk Road Medical. Silk Road Medical's average media sentiment score of 1.45 beat OrthoPediatrics' score of 0.48 indicating that Silk Road Medical is being referred to more favorably in the media.
OrthoPediatrics has lower revenue, but higher earnings than Silk Road Medical. OrthoPediatrics is trading at a lower price-to-earnings ratio than Silk Road Medical, indicating that it is currently the more affordable of the two stocks.
69.1% of OrthoPediatrics shares are held by institutional investors. 6.7% of Silk Road Medical shares are held by insiders. Comparatively, 31.8% of OrthoPediatrics shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
OrthoPediatrics received 216 more outperform votes than Silk Road Medical when rated by MarketBeat users. Likewise, 64.56% of users gave OrthoPediatrics an outperform vote while only 50.56% of users gave Silk Road Medical an outperform vote.
OrthoPediatrics has a net margin of -13.58% compared to Silk Road Medical's net margin of -29.02%. OrthoPediatrics' return on equity of -5.12% beat Silk Road Medical's return on equity.
Summary
OrthoPediatrics beats Silk Road Medical on 13 of the 18 factors compared between the two stocks.
Get Silk Road Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for SILK and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding SILK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Silk Road Medical Competitors List
Related Companies and Tools
